Noa Shelach

Companies

Lutris Pharma is developing the topical B-Raf inhibitor LUT014, a proprietary small molecule allowing administration of...

www.lutris-pharma.com

[1]

crunchbase.com - https://www.crunchbase.com/person/noa-shelach

External links are provided for reference and verification purposes.